KKAMG
GSK icon

Kernodle & Katon Asset Management Group’s GSK GSK Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.42M Buy
26,939
+1,557
+6% +$79K 0.85% 34
2016
Q4 		$1.22M Buy
25,382
+4,462
+21% +$220K 0.73% 45
2016
Q3 		$1.13M Buy
20,920
+19,833
+1,825% +$1.09M 0.7% 45
2016
Q2 		$59K Hold
1,087
– – 0.05% 128
2016
Q1 		$55K Hold
1,087
– – 0.05% 120
2015
Q4 		$55K Buy
+1,087
New +$55.4K 0.05% 108

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Kernodle & Katon Asset Management Group's GSK Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group increased its GSK (GSK) stake by 6.1% in Q1 2017, buying an estimated $79K and bringing the position to 26,939 shares worth $1.42M. The position accounts for 0.85% of the portfolio, ranked #34.

Kernodle & Katon Asset Management Group first reported a position in GSK in Q4 2015 and has held it in 6 quarters since. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

  • Kernodle & Katon Asset Management Group held 26,939 shares of GSK worth $1.42M as of Q1 2017.
  • Kernodle & Katon Asset Management Group bought 1,557 GSK shares in Q1 2017, an estimated $79K.
  • GSK made up 0.85% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #34 holding.
  • Kernodle & Katon Asset Management Group first reported a position in GSK in Q4 2015 and has held it in 6 quarters since.
  • 786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.